Loading...

Global Aging And Emerging Markets Will Expand Eye Care

Published
19 Mar 25
Updated
23 Aug 25
AnalystConsensusTarget's Fair Value
CHF 81.30
24.6% undervalued intrinsic discount
04 Sep
CHF 61.28
Loading
1Y
-25.7%
7D
-2.2%

Author's Valuation

CHF 81.3

24.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on23 Aug 25
Fair value Decreased 7.39%

Alcon's consensus price target has been revised downward, primarily reflecting a significantly lower future P/E multiple despite improved revenue growth forecasts, resulting in a new fair value estimate of CHF82.40. What's in the News Alcon updated 2025 net sales guidance to $10.3–$10.4 billion, slightly down from the previous $10.4–$10.5 billion, while reaffirming Core diluted EPS at $3.05–$3.15.

Shared on01 May 25
Fair value Decreased 0.64%

Shared on24 Apr 25
Fair value Decreased 0.55%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 2.73%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 2.37%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 3.82%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 5.53%

AnalystConsensusTarget has decreased revenue growth from 7.1% to 6.2% and decreased shares outstanding growth rate from 0.0% to 0.0%.